These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38578507)

  • 21. Current insights into the treatments of severe aplastic anemia in China.
    Ye L; Zhang F; Kojima S
    Int J Hematol; 2020 Sep; 112(3):292-299. PubMed ID: 32748215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy.
    Guan J; Sun Y; Fu R; Wang H; Ruan E; Wang X; Qu W; Wang G; Liu H; Wu Y; Song J; Xing L; Li L; Liu H; Liu C; Shao Z
    Medicine (Baltimore); 2019 Jan; 98(3):e14149. PubMed ID: 30653151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
    Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
    Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
    Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
    Front Immunol; 2022; 13():837335. PubMed ID: 35178053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and treatment outcome of aplastic anemia in Taiwan-real-world data from single-institute experience and a nationwide population-based database.
    Li SS; Hsu YT; Chang C; Lee SC; Yen CC; Cheng CN; Chen JS; Lin SH; Chang KC; Chen TY
    Ann Hematol; 2019 Jan; 98(1):29-39. PubMed ID: 30178191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
    Assi R; Garcia-Manero G; Ravandi F; Borthakur G; Daver NG; Jabbour E; Burger J; Estrov Z; Dinardo CD; Alvarado Y; Hendrickson S; Ferrajoli A; Wierda W; Cortes J; Kantarjian H; Kadia TM
    Cancer; 2018 Nov; 124(21):4192-4201. PubMed ID: 30307606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The impact of immunosuppressive therapy on genetic instabilities of bone marrow hematopoietic cells in patients with aplastic anemia].
    Zhang LH; Wang HJ; Zhang L; Zhou K; Yang DL; Yan ZS; Li HQ; Liu QG; Qi JY; Liu Q; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):728-32. PubMed ID: 19176006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC).
    Williams DA; Bennett C; Bertuch A; Bessler M; Coates T; Corey S; Dror Y; Huang J; Lipton J; Olson TS; Reiss UM; Rogers ZR; Sieff C; Vlachos A; Walkovich K; Wang W; Shimamura A
    Pediatr Blood Cancer; 2014 May; 61(5):869-74. PubMed ID: 24285674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aplastic anemia in children: How good is immunosuppressive therapy?
    Jain R; Trehan A; Bansal D; Varma N
    Pediatr Hematol Oncol; 2019 May; 36(4):211-221. PubMed ID: 31287349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis.
    Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
    BMC Immunol; 2020 Mar; 21(1):10. PubMed ID: 32138642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
    Kook H; Chung NG; Kang HJ; Im HJ
    Int J Hematol; 2016 Apr; 103(4):380-6. PubMed ID: 26894608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of aplastic anemia after failure of frontline immunosuppression.
    Pierri F; Dufour C
    Expert Rev Hematol; 2019 Oct; 12(10):809-819. PubMed ID: 31311355
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study.
    Zhu XF; He HL; Wang SQ; Tang JY; Han B; Zhang DH; Wu LQ; Wu DP; Li W; Xia LH; Zhu HL; Liu F; Shi HX; Zhang X; Zhou F; Hu JD; Fang JP; Chen XQ; Ye TZ; Liang YM; Jin J; Zhang FK
    Acta Haematol; 2019; 142(3):162-170. PubMed ID: 31091521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.
    Escalante CP; Chisolm S; Song J; Richardson M; Salkeld E; Aoki E; Garcia-Manero G
    Cancer Med; 2019 Feb; 8(2):543-553. PubMed ID: 30632713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
    Suzuki K; Muramatsu H; Okuno Y; Narita A; Hama A; Takahashi Y; Yoshida M; Horikoshi Y; Watanabe K; Kudo K; Kojima S
    Int J Hematol; 2016 Jul; 104(1):130-3. PubMed ID: 27107757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007-2016)].
    Mikhaylova EA; Fidarova ZT; Abramova AV; Luchkin AV; Troitskaya VV; Dvirnyk VN; Galtseva IV; Kliasova GA; Kovrigina AM; Kulikov SM; Chabaeva YА; Parovichnikova EN; Savchenko VG; Obukhova TN
    Ter Arkh; 2020 Sep; 92(7):4-9. PubMed ID: 33346440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.